Why the study?
Does paricalcitol attenuate cardiac fibrosis in isoproterenol-induced cardiomyopathic rats?
Does paricalcitol attenuate cardiac fibrosis in isoproterenol-induced cardiomyopathic rats?
Paricalcitol may ameliorate isoproterenol-induced cardiac fibrosis in a rat model of acute cardiomyopathy, potentially by regulating endothelial cell transition.
Does not support paricalcitol use in cardiomyopathy; hypothesis-generating for cardiac fibrosis in animal models.
No takes yet. Share an insight, caveat, or question.
Lai et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: